Proposed Data Collection Submitted for Public Comment and Recommendations, 96461-96462 [2016-31737]
Download as PDF
Federal Register / Vol. 81, No. 251 / Friday, December 30, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–17–17IX; Docket No. CDC–2016–
0124]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project entitled ‘‘Assessment
of Interventions Intended to Protect
Pregnant Women in Puerto Rico from
Zika Infections.’’ This project consists of
telephone interviews with pregnant WIC
participants in Puerto Rico.
DATES: Written comments must be
received on or before February 28, 2017.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2016–
0124 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment
should be submitted through the
Federal eRulemaking portal
(Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
srobinson on DSK5SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:18 Dec 29, 2016
Jkt 241001
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Assessment of Interventions Intended
to Protect Pregnant Women in Puerto
Rico from Zika Infections—New—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
96461
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC proposes to continue the
information collection initially cleared
by OMB as an emergency ICR in June,
2016 (OMB Control No. 0920–1118).
The expiration date for 0920–1118 is
December 31, 2016. However, CDC
intends to continue information
collection for an additional nine months
and is seeking OMB clearance to do so.
In December 2015, the
Commonwealth of Puerto Rico, a United
States territory, reported its first
confirmed locally transmitted Zika virus
case.
Starting in March 2016, The Centers
for Disease Control and Prevention’s
(CDC) National Center for Emerging and
Zoonotic Infections Diseases (NCEZID)
initiated several interventions targeting
pregnant women. The ultimate goal of
these interventions is/was to protect
pregnant women from Zika virus and
encourage Zika prevention behaviors
among pregnant women. The
interventions include the following:
1. Zika Education Sessions (at WIC
clinics;
2. Zika Prevention Kits;
3. Communication activities; and
4. Vector control services in the
community.
This ICR is for data collection over the
next nine months related to Zika
prevention efforts that have been and
will be implemented in Puerto Rico.
Specifically, CDC needs this assessment
to ensure that Zika prevention activities
effectively educate, equip, and
encourage women to participate in as
many Zika prevention behaviors as
possible. On-going evaluation is an
important part of this program because
it can reveal novel ways that women
protect themselves from Zika, how
effective the distribution of the Zika
Prevention Kit has been in Puerto Rico,
perceived severity and susceptibility to
Zika, pregnant women’s self-efficacy in
protecting themselves from Zika after
the interventions have been
implemented, as well as the extent to
which target populations are using
contents of the Zika Prevention Kit.
Interviews with pregnant women in
Puerto Rico can help articulate
motivations for and against engaging in
Zika prevention behaviors that are
critical for preventing Zika-associated
birth defects and morbidities.
Implementing changes based on results
from this assessment is expected to
facilitate program improvement and
ensure the most efficient allocation of
resources for this public health
emergency. The goal of this project is to
E:\FR\FM\30DEN1.SGM
30DEN1
96462
Federal Register / Vol. 81, No. 251 / Friday, December 30, 2016 / Notices
find out if interventions are reaching
pregnant women and having the
intended effects along with getting
feedback from pregnant women about
the Zika prevention activities that have
been implemented (e.g., Zika education
sessions and prevention kits, vector
control activities, and communication
activities).
Findings will be used to improve the
delivery of interventions and to inform
decisions about future Zika prevention
activities for pregnant women in Puerto
Rico. The plan is to conduct up to 500
telephone interviews every two months
over a 9-month period, (a total of four
rounds), analyze the data, and generate
a report for leaders of the response to
offer insights on the delivery of
interventions to pregnant women. The
information will be used to make
recommendations for improving
interventions. Information may also be
used to develop presentations, reports,
and manuscripts to document the
program and lessons learned in order to
inform future programs of this sort.
The purpose of this assessment is also
to assess core components of CDC’s Zika
response in communicating prevention
behaviors, risk messages to the public
contraception, mental health/emotional
support, service/support needs of
families with babies affected by Zika, or
vaccine communications (if applicable).
While pregnant women will be the main
focus of most inquiry, other audiences
could include community leaders,
community members, and health care
providers. The goal is to identify
specific unmet needs, which can then
be shared with the Department of Health
and other human service agencies. The
plan is to hold up to 7 focus groups
(with up to 10 persons each), or up to
20 in-depth individual interviews or up
to 75 brief intercept interviews. A
maximum of 75 individuals would
participate in this part.
Results of this project will have
limited generalizability. However,
results of this evaluation should provide
information that can be used to enhance
and revise the existing program as well
as offer lessons learned to inform
infectious disease control programs that
use education materials.
Authorizing legislation comes from
Section 301 of the Public Health Service
Act (42 U.S.C. 241). There is no cost to
respondents other than their time to
participate.
about vector control activities, and the
Zika Prevention kit.
The following factors will be assessed:
• Knowledge about Zika virus and
related prevention behaviors
• Self-efficacy in engaging in Zika
prevention behaviors
• Engagement in Zika prevention
behaviors (e.g., protective clothing
use, condom use, and bed net use)
• Knowledge about, attitudes about, and
use of the Zika Prevention Kit
materials
• Knowledge about, attitudes about, and
use of environmental vector control
activities
• Risk perceptions of Zika
• Exposures to communications along
with other factors that may be
important considerations in their
taking action or not (e.g., does their
house have screens, etc.)
CDC will conduct telephone
interviews with a mix of closed-ended
and open-ended questions with
pregnant women. We estimate 2,000
pregnant women will participate in the
project over a nine month period.
Another component of this project is
to conduct qualitative inquiry to explore
emerging issues related to vector
control, sexual transmission,
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hrs.)
Total burden
(in hrs.)
Type of respondents
Form name
Pregnant WIC participant .....................................
Initial Telephone Interview.
Focus group .................
In-depth Interviews .......
Brief intercept interview
2,000
1
20/60
667
70
20
75
1
1
1
120/60
60/60
10/60
140
20
13
.......................................
........................
........................
........................
840
WIC participants, other families affected by Zika
WIC participants, other families ............................
General population in Zika affected neighborhood.
Total ...............................................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2016–31737 Filed 12–29–16; 8:45 am]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Food Labeling
Regulations
BILLING CODE 4163–18–P
Food and Drug Administration
[Docket No. FDA–2013–N–1155]
srobinson on DSK5SPTVN1PROD with NOTICES
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or we) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
SUMMARY:
VerDate Sep<11>2014
19:18 Dec 29, 2016
Jkt 241001
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
1995 (the PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the information
collection provisions of our food
labeling regulations and on Form FDA
3570, Model Small Business Nutrition
Labeling Exemption Notice, which
small businesses may use to claim the
small business exemption from
nutrition labeling.
Submit either electronic or
written comments on the collection of
information by February 28, 2017.
DATES:
E:\FR\FM\30DEN1.SGM
30DEN1
Agencies
[Federal Register Volume 81, Number 251 (Friday, December 30, 2016)]
[Notices]
[Pages 96461-96462]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31737]
[[Page 96461]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-17-17IX; Docket No. CDC-2016-0124]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project entitled ``Assessment of Interventions
Intended to Protect Pregnant Women in Puerto Rico from Zika
Infections.'' This project consists of telephone interviews with
pregnant WIC participants in Puerto Rico.
DATES: Written comments must be received on or before February 28,
2017.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2016-
0124 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact the Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services
to provide information. Burden means the total time, effort, or
financial resources expended by persons to generate, maintain, retain,
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; to develop, acquire,
install and utilize technology and systems for the purpose of
collecting, validating and verifying information, processing and
maintaining information, and disclosing and providing information; to
train personnel and to be able to respond to a collection of
information, to search data sources, to complete and review the
collection of information; and to transmit or otherwise disclose the
information.
Proposed Project
Assessment of Interventions Intended to Protect Pregnant Women in
Puerto Rico from Zika Infections--New--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC proposes to continue the information collection initially
cleared by OMB as an emergency ICR in June, 2016 (OMB Control No. 0920-
1118). The expiration date for 0920-1118 is December 31, 2016. However,
CDC intends to continue information collection for an additional nine
months and is seeking OMB clearance to do so.
In December 2015, the Commonwealth of Puerto Rico, a United States
territory, reported its first confirmed locally transmitted Zika virus
case.
Starting in March 2016, The Centers for Disease Control and
Prevention's (CDC) National Center for Emerging and Zoonotic Infections
Diseases (NCEZID) initiated several interventions targeting pregnant
women. The ultimate goal of these interventions is/was to protect
pregnant women from Zika virus and encourage Zika prevention behaviors
among pregnant women. The interventions include the following:
1. Zika Education Sessions (at WIC clinics;
2. Zika Prevention Kits;
3. Communication activities; and
4. Vector control services in the community.
This ICR is for data collection over the next nine months related
to Zika prevention efforts that have been and will be implemented in
Puerto Rico. Specifically, CDC needs this assessment to ensure that
Zika prevention activities effectively educate, equip, and encourage
women to participate in as many Zika prevention behaviors as possible.
On-going evaluation is an important part of this program because it can
reveal novel ways that women protect themselves from Zika, how
effective the distribution of the Zika Prevention Kit has been in
Puerto Rico, perceived severity and susceptibility to Zika, pregnant
women's self-efficacy in protecting themselves from Zika after the
interventions have been implemented, as well as the extent to which
target populations are using contents of the Zika Prevention Kit.
Interviews with pregnant women in Puerto Rico can help articulate
motivations for and against engaging in Zika prevention behaviors that
are critical for preventing Zika-associated birth defects and
morbidities. Implementing changes based on results from this assessment
is expected to facilitate program improvement and ensure the most
efficient allocation of resources for this public health emergency. The
goal of this project is to
[[Page 96462]]
find out if interventions are reaching pregnant women and having the
intended effects along with getting feedback from pregnant women about
the Zika prevention activities that have been implemented (e.g., Zika
education sessions and prevention kits, vector control activities, and
communication activities).
Findings will be used to improve the delivery of interventions and
to inform decisions about future Zika prevention activities for
pregnant women in Puerto Rico. The plan is to conduct up to 500
telephone interviews every two months over a 9-month period, (a total
of four rounds), analyze the data, and generate a report for leaders of
the response to offer insights on the delivery of interventions to
pregnant women. The information will be used to make recommendations
for improving interventions. Information may also be used to develop
presentations, reports, and manuscripts to document the program and
lessons learned in order to inform future programs of this sort.
The purpose of this assessment is also to assess core components of
CDC's Zika response in communicating prevention behaviors, risk
messages to the public about vector control activities, and the Zika
Prevention kit.
The following factors will be assessed:
Knowledge about Zika virus and related prevention behaviors
Self-efficacy in engaging in Zika prevention behaviors
Engagement in Zika prevention behaviors (e.g., protective
clothing use, condom use, and bed net use)
Knowledge about, attitudes about, and use of the Zika
Prevention Kit materials
Knowledge about, attitudes about, and use of environmental
vector control activities
Risk perceptions of Zika
Exposures to communications along with other factors that may
be important considerations in their taking action or not (e.g., does
their house have screens, etc.)
CDC will conduct telephone interviews with a mix of closed-ended
and open-ended questions with pregnant women. We estimate 2,000
pregnant women will participate in the project over a nine month
period.
Another component of this project is to conduct qualitative inquiry
to explore emerging issues related to vector control, sexual
transmission, contraception, mental health/emotional support, service/
support needs of families with babies affected by Zika, or vaccine
communications (if applicable). While pregnant women will be the main
focus of most inquiry, other audiences could include community leaders,
community members, and health care providers. The goal is to identify
specific unmet needs, which can then be shared with the Department of
Health and other human service agencies. The plan is to hold up to 7
focus groups (with up to 10 persons each), or up to 20 in-depth
individual interviews or up to 75 brief intercept interviews. A maximum
of 75 individuals would participate in this part.
Results of this project will have limited generalizability.
However, results of this evaluation should provide information that can
be used to enhance and revise the existing program as well as offer
lessons learned to inform infectious disease control programs that use
education materials.
Authorizing legislation comes from Section 301 of the Public Health
Service Act (42 U.S.C. 241). There is no cost to respondents other than
their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hrs.)
respondent hrs.)
----------------------------------------------------------------------------------------------------------------
Pregnant WIC participant...... Initial 2,000 1 20/60 667
Telephone
Interview.
WIC participants, other Focus group..... 70 1 120/60 140
families affected by Zika.
WIC participants, other In-depth 20 1 60/60 20
families. Interviews.
General population in Zika Brief intercept 75 1 10/60 13
affected neighborhood. interview.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 840
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-31737 Filed 12-29-16; 8:45 am]
BILLING CODE 4163-18-P